Cargando…
FDG-PET/CT lymph node staging after neoadjuvant chemotherapy in patients with adenocarcinoma of the esophageal–gastric junction
OBJECTIVES: The aim of the analysis was to assess the accuracy of various FDG-PET/CT parameters in staging lymph nodes after neoadjuvant chemotherapy. METHODS: In this prospective study, 74 patients with adenocarcinoma of the esophageal–gastric junction were examined by FDG-PET/CT in the course of t...
Autores principales: | Fencl, Pavel, Belohlavek, Otakar, Harustiak, Tomas, Zemanova, Milada |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059406/ https://www.ncbi.nlm.nih.gov/pubmed/27405645 http://dx.doi.org/10.1007/s00261-016-0820-x |
Ejemplares similares
-
PET/CT-tailored treatment of locally advanced oesophago-gastric
junction adenocarcinoma: a report on the feasibility of the multicenter
GastroPET study
por: Obermannova, Radka, et al.
Publicado: (2022) -
Feasibility of FDG PET/CT to monitor the response of axillary lymph node metastases to neoadjuvant chemotherapy in breast cancer patients
por: Straver, Marieke E., et al.
Publicado: (2010) -
FDG-PET/CT for lymph node staging prior to radical cystectomy
por: Pihl, Vilhelm, et al.
Publicado: (2023) -
Evaluation of Mediastinal Lymph Nodes in Sarcoidosis, Sarcoid Reaction, and Malignant Lymph Nodes Using CT and FDG-PET/CT
por: Koo, Hyun Jung, et al.
Publicado: (2015) -
Occult mediastinal lymph node metastasis in FDG‐PET/CT node‐negative lung adenocarcinoma patients: Risk factors and histopathological study
por: Miao, Huang, et al.
Publicado: (2019)